PhysioCue Inc.
PhysioCue has developed a non-invasive hypertension therapy device and a migraine and headache therapy device.
6 employees · est. 2014 · San Jose, United States
PhysioCue Inc. is the older company (2014 vs 2016); Satsuma Pharmaceuticals, Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | PhysioCue Inc. | Satsuma Pharmaceuticals, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2014 older | 2016 |
| Headquarters | ||
| Headquarters | San Jose, United States | South San Francisco, United States |
| Employees | ||
| Employees | 6 | 25 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Medical Devices | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Seed | Post Ipo Equity |
| Total Funding | ||
| Total Funding | Not tracked yet | $154.00M |
| Funding Rounds | ||
| Funding Rounds | 3 | 3 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Non-invasive Therapy, Blood Pressure Relief, Migraine/headache Relief, Clinical Trials, Controlled Cold Therapy, Carotid Artery Baroreceptor Reflex, Anti-hypertensive Treatment, User-friendly, Wearable Health Device | Biopharmaceutical Company, Clinical-stage, Migraine Treatment, Therapeutic Product, Product Candidate, DHE Nasal Powder, Drug-device Combination, Novel Treatments, Acute Treatment, Nasal Delivery Device |
| Website | ||
| Website | physiocue.com | satsumarx.com |
About PhysioCue Inc.
PhysioCue is a biotechnology and healthcare startup founded in 2013, with a focus on developing non-invasive medical devices for hypertension and migraine relief. The company's products have undergone clinical trials and have demonstrated efficacy in lowering high blood pressure and alleviating migr...
About Satsuma Pharmaceuticals, Inc.
Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company founded in 2016, with a focus on providing innovative treatments for migraine and other debilitating conditions. Their flagship product candidate, STS101 (dihydroergotamine (DHE) nasal powder), is being developed as a differ...
We will tell you when either one moves
BounceWatch watches PhysioCue Inc. and Satsuma Pharmaceuticals, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at PhysioCue Inc. and Satsuma Pharmaceutical... — by email.
Frequently Asked Questions
Compare PhysioCue Inc. with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at PhysioCue Inc. on 12 Sep 2024, and Satsuma Pharmaceuticals, Inc. on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.